Fig. 1From: Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: expert panel reviewDosing strategies for bosutinib therapy in CP-CML Abbreviations: AEs, adverse events; CP chronic-phase; CML chronic myeloid leukemia; TKI, tyrosine kinase inhibitorBack to article page